155 related articles for article (PubMed ID: 37195580)
1. Acromegaly complicated with fulminant pituitary apoplexy: clinical characteristic analysis and review of literature.
Zheng XQ; Zhou X; Yao Y; Deng K; You H; Duan L; Zhu HJ
Endocrine; 2023 Jul; 81(1):160-167. PubMed ID: 37195580
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
3. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
Duan L; Zhu H; Xing B; Gu F
BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous remission of acromegaly after infarctive apoplexy with a possible relation to MRI and diabetes mellitus.
Cinar N; Metin Y; Dagdelen S; Ziyal MI; Soylemezoglu F; Erbas T
Neuro Endocrinol Lett; 2013; 34(5):339-42. PubMed ID: 23922047
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C; Oearsakul T
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor apoplexy in patients with Cushing's disease: endocrinologic and visual outcomes after transsphenoidal surgery.
Choudhry OJ; Choudhry AJ; Nunez EA; Eloy JA; Couldwell WT; Ciric IS; Liu JK
Pituitary; 2012 Sep; 15(3):428-35. PubMed ID: 21927887
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous remission of acromegaly and Cushing's disease following pituitary apoplexy: Two case reports.
Roerink SH; van Lindert EJ; van de Ven AC
Neth J Med; 2015 Jun; 73(5):242-6. PubMed ID: 26087804
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma.
Wang XL; Dou JT; Lü ZH; Zhong WW; Ba JM; Jin D; Lu JM; Pan CY; Mu YM
Chin Med J (Engl); 2011 Nov; 124(22):3820-3. PubMed ID: 22340248
[TBL] [Abstract][Full Text] [Related]
10. Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
Karavitaki N; Turner HE; Adams CB; Cudlip S; Byrne JV; Fazal-Sanderson V; Rowlers S; Trainer PJ; Wass JA
Clin Endocrinol (Oxf); 2008 Jun; 68(6):970-5. PubMed ID: 18031313
[TBL] [Abstract][Full Text] [Related]
11. Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study.
Shen M; Shou X; Wang Y; Zhang Z; Wu J; Mao Y; Li S; Zhao Y
Endocr J; 2010; 57(12):1035-44. PubMed ID: 21099129
[TBL] [Abstract][Full Text] [Related]
12. Remission of acromegaly after pituitary apoplexy: case report and review of literature.
Fraser LA; Lee D; Cooper P; Van Uum S
Endocr Pract; 2009; 15(7):725-31. PubMed ID: 19546053
[TBL] [Abstract][Full Text] [Related]
13. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.
Zhang S; Chen J; Yao S; Akter F; Wang Z; Hu B; Zhu D; Duan C; Chen W; Zhu Y; Wang H; Mao Z
J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731
[TBL] [Abstract][Full Text] [Related]
14. Management and outcomes of pituitary apoplexy.
Singh TD; Valizadeh N; Meyer FB; Atkinson JL; Erickson D; Rabinstein AA
J Neurosurg; 2015 Jun; 122(6):1450-7. PubMed ID: 25859804
[TBL] [Abstract][Full Text] [Related]
15. Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months.
Elsässer Imboden PN; De Tribolet N; Lobrinus A; Gaillard RC; Portmann L; Pralong F; Gomez F
Medicine (Baltimore); 2005 May; 84(3):188-196. PubMed ID: 15879908
[TBL] [Abstract][Full Text] [Related]
16. Pituitary apoplexy: An emergent and potential life-threatening complication of pituitary adenomas.
Geyik AM; Durmaz MO; Dogan A; Kaya Uğur B; Geyik S; Erkutlu İ; Yasar S; Kırık A; Kose G; Nehir A
Ulus Travma Acil Cerrahi Derg; 2022 Apr; 28(4):483-489. PubMed ID: 35485523
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment for severe visual compromised patients after pituitary apoplexy.
Chuang CC; Chang CN; Wei KC; Liao CC; Hsu PW; Huang YC; Chen YL; Lai LJ; Pai PC
J Neurooncol; 2006 Oct; 80(1):39-47. PubMed ID: 16645717
[TBL] [Abstract][Full Text] [Related]
18. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
[TBL] [Abstract][Full Text] [Related]
19. Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage.
Hosmann A; Micko A; Frischer JM; Roetzer T; Vila G; Wolfsberger S; Knosp E
World Neurosurg; 2019 Jun; 126():e723-e730. PubMed ID: 30851467
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas.
Nakhleh A; Assaliya Naffa M; Sviri G; Shehadeh N; Hochberg I
Pituitary; 2021 Aug; 24(4):492-498. PubMed ID: 33462744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
